Surgery Following EGFR TKI Therapy Shows Potential to Extend Progression-Free Survival in Metastatic NSCLC
(Barcelona, Spain, September 9, 2025, 10:15 a.m. CEST / UTC +2) — Groundbreaking findings from a randomized Phase II clinical ...
(Barcelona, Spain, September 9, 2025, 10:15 a.m. CEST / UTC +2) — Groundbreaking findings from a randomized Phase II clinical ...
In a groundbreaking advancement for the management of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
Groundbreaking Phase III Trial Demonstrates Superior Efficacy of Aumolertinib Plus Chemotherapy in Advanced EGFR-Mutant NSCLC In a pivotal advancement for ...
In a groundbreaking development in the treatment of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
In a groundbreaking multicenter retrospective study published in BMC Cancer, researchers have delved into the crucial question of how young ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine